Used in research for inflammatory diseases, particularly as a selective TYK2 inhibitor. Helps modulate immune responses by targeting cytokine signaling pathways involved in conditions like psoriasis and lupus. Investigated for its potential in autoimmune disorders due to its ability to suppress pro-inflammatory mediators without broad immunosuppression. Not approved for clinical use; primarily utilized in preclinical studies to evaluate efficacy and safety profiles.